Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026)
Vertex Pharmaceuticals' quarterly Asset Utilization Ratio came in at 0.47 in Q1 2026, down 4.1% year-on-year from 0.49 in Q1 2025, and down 1.36% quarter-over-quarter from 0.48 in Q4 2025.
Vertex Pharmaceuticals has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.47 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 4.1% year-over-year to 0.47; the trailing twelve-month figure through Mar 2026 stood at 0.47 (down 4.1% YoY), and the FY2025 full-year result was 0.5, up 2.32% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.47, down from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.57 in Q1 2022, with the low at 0.44 in Q1 2024.
- Average Asset Utilization Ratio over 5 years is 0.49, with a median of 0.49 recorded in 2025.
- Year-over-year, Asset Utilization Ratio declined 14.85% in 2023 and advanced 11.94% in 2025.
- Tracing VRTX's Asset Utilization Ratio over 5 years: stood at 0.51 in 2022, then decreased by 13.35% to 0.44 in 2023, then grew by 10.87% to 0.49 in 2024, then retreated by 3.46% to 0.48 in 2025, then declined by 1.36% to 0.47 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.47 (Q1 2026), 0.48 (Q4 2025), and 0.48 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.51 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.58 |
| Sep 30, 2021 | 0.57 |
| Jun 30, 2021 | 0.55 |
| Mar 31, 2021 | 0.54 |
| Dec 31, 2020 | 0.54 |
| Sep 30, 2020 | 0.44 |
| Jun 30, 2020 | 0.43 |
| Mar 31, 2020 | 0.41 |
| Dec 31, 2019 | 0.37 |
| Sep 30, 2019 | 0.50 |
| Jun 30, 2019 | 0.51 |
| Mar 31, 2019 | 0.51 |
| Dec 31, 2018 | 0.56 |
| Sep 30, 2018 | 0.63 |
| Jun 30, 2018 | 0.63 |
| Mar 31, 2018 | 0.64 |
| Dec 31, 2017 | 0.74 |
| Sep 30, 2017 | 0.71 |
| Jun 30, 2017 | 0.68 |
| Mar 31, 2017 | 0.69 |
| Dec 31, 2016 | 0.61 |
| Sep 30, 2016 | 0.64 |
| Jun 30, 2016 | 0.61 |
| Mar 31, 2016 | 0.51 |
| Dec 31, 2015 | 0.41 |
| Sep 30, 2015 | 0.31 |
| Jun 30, 2015 | 0.25 |
| Mar 31, 2015 | 0.24 |
| Dec 31, 2014 | 0.22 |
| Sep 30, 2014 | 0.22 |
| Jun 30, 2014 | 0.27 |
| Mar 31, 2014 | 0.32 |
| Dec 31, 2013 | 0.38 |
| Sep 30, 2013 | 0.44 |
| Jun 30, 2013 | 0.50 |
| Mar 31, 2013 | 0.55 |
| Dec 31, 2012 | 0.53 |
| Sep 30, 2012 | 0.64 |
| Jun 30, 2012 | 0.72 |
| Mar 31, 2012 | 0.63 |
| Dec 31, 2011 | 0.52 |
| Mar 31, 2011 | 0.12 |
| Dec 31, 2010 | 0.08 |
| Sep 30, 2010 | 0.06 |
| Jun 30, 2010 | 0.07 |
| Mar 31, 2010 | 0.05 |